Bicara Therapeutics Inc (NASDAQ: BCAX) started the day on Wednesday, with a price decrease of -7.08% at $15.88, before settling in for the price of $17.09 at the close. Taking a more long-term approach, BCAX posted a 52-week range of $7.80-$28.09.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 43.65%. This publicly-traded company’s shares outstanding now amounts to $54.56 million, simultaneously with a float of $30.99 million. The organization now has a market capitalization sitting at $867.25 million. At the time of writing, stock’s 50-day Moving Average stood at $14.15, while the 200-day Moving Average is $12.55.
Bicara Therapeutics Inc (BCAX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Bicara Therapeutics Inc’s current insider ownership accounts for 43.26%, in contrast to 64.08% institutional ownership. According to the most recent insider trade that took place on Oct 15 ’25, this organization’s President and COO sold 12,500 shares at the rate of 18.16, making the entire transaction reach 226,942 in total value, affecting insider ownership by 198,141.
Bicara Therapeutics Inc (BCAX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.54 per share during the current fiscal year.
Bicara Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 43.65% and is forecasted to reach -2.62 in the upcoming year.
Bicara Therapeutics Inc (NASDAQ: BCAX) Trading Performance Indicators
Let’s observe the current performance indicators for Bicara Therapeutics Inc (BCAX). It’s Quick Ratio in the last reported quarter now stands at 25.80.
In the same vein, BCAX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.89, a figure that is expected to reach -0.54 in the next quarter, and analysts are predicting that it will be -2.62 at the market close of one year from today.
Technical Analysis of Bicara Therapeutics Inc (BCAX)
If we take a close look at the recent performances of Bicara Therapeutics Inc (NASDAQ: BCAX), its last 5-days Average volume was 0.66 million that shows progress from its year to date volume of 0.6 million. During the previous 9 days, stock’s Stochastic %D was recorded 48.88% While, its Average True Range was 41.59.
Raw Stochastic average of Bicara Therapeutics Inc (BCAX) in the period of the previous 100 days is set at 65.89%, which indicates a major rise in contrast to 29.14% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.36 that was higher than 0.83 volatility it exhibited in the past 100-days period.
